Additionally, the degree of liver steatosis and inflammatory cell infiltration in the intervention group was also reduced relative to the model group; based on these results, it was speculated that probiotics may delay the process of NAFLD by inhibiting the LPS–TLR4 signaling pathway [70]. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.